Molecular Templates, Inc. (NASDAQ:MTEM) Major Shareholder Sells $844,681.20 in Stock

Molecular Templates, Inc. (NASDAQ:MTEM) major shareholder Target N. V. Biotech sold 1,279,820 shares of the company’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $0.66, for a total transaction of $844,681.20. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Molecular Templates Stock Down 3.1 %

Shares of NASDAQ:MTEM traded down $0.01 on Monday, reaching $0.45. 10,064,368 shares of the company’s stock were exchanged, compared to its average volume of 2,838,425. Molecular Templates, Inc. has a fifty-two week low of $0.30 and a fifty-two week high of $5.37. The business’s 50-day moving average is $0.91 and its two-hundred day moving average is $1.21. The firm has a market capitalization of $2.98 million, a price-to-earnings ratio of -0.17 and a beta of 1.22.

About Molecular Templates

Molecular Templates, Inc, a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB).